Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)-A Single Center, Retrospective Observational Study. | Int J Mol Sci | 2022 | 36293366 | PubTator, text mining | PubMed |
| Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations. | Cancers (Basel) | 2022 | 36291897 | PubTator, text mining | PubMed |
| Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas. | Cancers (Basel) | 2022 | 36291806 | PubTator, text mining | PubMed |
| Latest Advances in the Management of Pediatric Gastrointestinal Stromal Tumors. | Cancers (Basel) | 2022 | 36291774 | PubTator, text mining | PubMed |
| Diagnosis, Treatment and Prognosis of Primary Pulmonary NUT Carcinoma: A Literature Review. | Curr Oncol | 2022 | 36290813 | PubTator, text mining | PubMed |
| Role of ferroptosis on tumor progression and immunotherapy. | Cell Death Discov | 2022 | 36289191 | PubTator, text mining | PubMed |
| Loss of the repressor REST affects progesterone receptor function and promotes uterine leiomyoma pathogenesis. | Proc Natl Acad Sci U S A | 2022 | 36282915 | PubTator, text mining | PubMed |
| Genetic and pharmacological tools to study the role of discoidin domain receptors in kidney disease. | Front Pharmacol | 2022 | 36249782 | PubTator, text mining | PubMed |
| Discoidin domain receptor 2 expression increases phagocytotic capacity in sertoli cells of sertoli cell-only syndrome testes. | Am J Transl Res | 2022 | 36247266 | PubTator, text mining | PubMed |
| The two facets of receptor tyrosine kinase in cardiovascular calcification-can tyrosine kinase inhibitors benefit cardiovascular system? | Front Cardiovasc Med | 2022 | 36237897 | PubTator, text mining | PubMed |
| Advances in the application of proteomics in lung cancer. | Front Oncol | 2022 | 36237335 | PubTator, text mining | PubMed |
| Collagen Type XI Inhibits Lung Cancer-Associated Fibroblast Functions and Restrains the Integrin Binding Site Availability on Collagen Type I Matrix. | Int J Mol Sci | 2022 | 36233024 | PubTator, text mining | PubMed |
| Molecular Mechanisms Driving the Formation of Brain Metastases. | Cancers (Basel) | 2022 | 36230886 | PubTator, text mining | PubMed |
| The Immune Contexture of Liposarcoma and Its Clinical Implications. | Cancers (Basel) | 2022 | 36230502 | PubTator, text mining | PubMed |
| Pharmacological basis of the antifibrotic effects of pirfenidone: Mechanistic insights from cardiac in-vitro and in-vivo models. | Front Cardiovasc Med | 2022 | 36204580 | PubTator, text mining | PubMed |
| High-throughput screen to identify compounds that prevent or target telomere loss in human cancer cells. | NAR Cancer | 2022 | 36196242 | PubTator, text mining | PubMed |
| Monitoring drug-target interactions through target engagement-mediated amplification on arrays and in situ. | Nucleic Acids Res | 2022 | 36189884 | PubTator, text mining | PubMed |
| How to read a next-generation sequencing report-what oncologists need to know. | ESMO Open | 2022 | 36183443 | PubTator, text mining | PubMed |
Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations. | Zhongguo Fei Ai Za Zhi | 2022 | 36172729 | PubTator, text mining | PubMed |
| Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming. | Cell Oncol (Dordr) | 2022 | 36169805 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=25